Clinical Trial Update: Improvement of Sensibility in the Foot in Diabetic Patients Induced by EMLA-application to the Lower Leg [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating whether applying EMLA cream to the lower leg improves foot sensibility in people with diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• EMLA Cream (lidocaine 2.5% / prilocaine 2.5% topical cream)

Snippet

Sponsor: Lund University Hospital | Conditions: Diabetes Mellitus | Phase 3 | Status: COMPLETED